By Galtec | November 13, 2023
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth
Fátima Ferragut, Alejandro J Cagnoni, Lucas L Colombo, Clara Sánchez Terrero, Carlota Wolfenstein-Todel, María F Troncoso, Silvia I Vanzulli, Gabriel A Rabinovich, Karina V Mariño, María T Elola